Nothing Special   »   [go: up one dir, main page]

EA200971077A1 - Гетероциклические модуляторы киназы - Google Patents

Гетероциклические модуляторы киназы

Info

Publication number
EA200971077A1
EA200971077A1 EA200971077A EA200971077A EA200971077A1 EA 200971077 A1 EA200971077 A1 EA 200971077A1 EA 200971077 A EA200971077 A EA 200971077A EA 200971077 A EA200971077 A EA 200971077A EA 200971077 A1 EA200971077 A1 EA 200971077A1
Authority
EA
Eurasian Patent Office
Prior art keywords
kinase modulators
heterocyclic kinase
heterocyclic
modulators
compounds
Prior art date
Application number
EA200971077A
Other languages
English (en)
Inventor
Пьер-ив Буно
Кристофер Рональд Смит
Элизабет А. Джефферсон
Йорг Хендле
Патрик С. Ли
Ангелина Мари Тэйер
Гэвин Чарльз Херст
Original Assignee
ЭсДжиЭкс ФАРМАСЬЮТИКАЛЗ, ИНК.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ЭсДжиЭкс ФАРМАСЬЮТИКАЛЗ, ИНК. filed Critical ЭсДжиЭкс ФАРМАСЬЮТИКАЛЗ, ИНК.
Publication of EA200971077A1 publication Critical patent/EA200971077A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

В настоящем изобретении предложены гетероциклические модуляторы протеинкиназы и способы применения указанных соединений для лечения заболеваний, опосредуемых киназной активностью.
EA200971077A 2007-05-21 2008-05-21 Гетероциклические модуляторы киназы EA200971077A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93931307P 2007-05-21 2007-05-21
PCT/US2008/064437 WO2008144767A1 (en) 2007-05-21 2008-05-21 Heterocyclic kinase modulators

Publications (1)

Publication Number Publication Date
EA200971077A1 true EA200971077A1 (ru) 2010-04-30

Family

ID=40122219

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200971077A EA200971077A1 (ru) 2007-05-21 2008-05-21 Гетероциклические модуляторы киназы

Country Status (11)

Country Link
US (1) US20090156594A1 (ru)
EP (1) EP2162132A4 (ru)
JP (1) JP2010528991A (ru)
KR (1) KR101156845B1 (ru)
CN (1) CN101678014B (ru)
AU (1) AU2008254588B2 (ru)
BR (1) BRPI0812360A2 (ru)
CA (1) CA2688823A1 (ru)
EA (1) EA200971077A1 (ru)
MX (1) MX2009012623A (ru)
WO (1) WO2008144767A1 (ru)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2660836A1 (en) 2006-08-07 2008-02-21 Incyte Corporation Triazolotriazines as kinase inhibitors
EP2099447B1 (en) 2006-11-22 2012-11-07 Incyte Corporation Imidazotriazines and imidazopyrimidines as kinase inhibitors
ES2548768T3 (es) 2007-09-27 2015-10-20 Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii Imidazolotiadiazoles para su uso como inhibidores de proteína quinasa
WO2009143211A2 (en) 2008-05-21 2009-11-26 Incyte Corporation Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
RU2011124894A (ru) 2008-11-19 2012-12-27 Вертекс Фармасьютикалз Инкорпорейтед Триазолотиадиазоловый ингибитор протеинкиназы с-мет
DK2414369T3 (en) 2009-04-02 2015-09-21 Fundacion Ct Nac Investigaciones Oncologicas Carlos Iii Imidazo [2,1-b] [1,3,4] thiadiazole derivatives
JP2012528185A (ja) * 2009-05-28 2012-11-12 バーテックス ファーマシューティカルズ インコーポレイテッド ｃ−Ｍｅｔタンパク質キナーゼの置換ピラゾール阻害剤
CN102448969A (zh) * 2009-05-28 2012-05-09 沃泰克斯药物股份有限公司 C-met蛋白激酶抑制剂
ES2433090T3 (es) * 2009-05-28 2013-12-09 Vertex Pharmaceuticals Incorporated Inhibidores a base de aminopirazol triazolotiadiazol de la proteína cinasa c-met
AU2010283806A1 (en) 2009-08-12 2012-03-01 Novartis Ag Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
JP5775871B2 (ja) 2009-08-20 2015-09-09 ノバルティス アーゲー ヘテロ環式オキシム化合物
US8343977B2 (en) 2009-12-30 2013-01-01 Arqule, Inc. Substituted triazolo-pyrimidine compounds
CN102812027B (zh) 2010-02-03 2015-01-07 因西特公司 作为C-MET抑制剂的咪唑并[1,2-b][1,2,4]三嗪
JP2013527195A (ja) * 2010-05-27 2013-06-27 バーテックス ファーマシューティカルズ インコーポレイテッド ｃ−Ｍｅｔプロテインキナーゼのアミノピラゾールトリアゾロチアジアゾールインヒビター
WO2012003338A1 (en) 2010-07-01 2012-01-05 Takeda Pharmaceutical Company Limited COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
CN103204862B (zh) * 2012-01-12 2014-12-17 清华大学深圳研究生院 6-苯基咪唑并[2，1-b]噻唑-3-酰胺类衍生物及其制备方法与应用
CN103204822B (zh) 2012-01-17 2014-12-03 上海科州药物研发有限公司 作为蛋白激酶抑制剂的苯并噁唑化合物及其制备方法和用途
AU2013269800A1 (en) * 2012-05-30 2014-10-09 F. Hoffmann-La Roche Ag Triazolo compounds as PDE10 inhibitors
EP2682395A1 (en) 2012-07-04 2014-01-08 Laboratorios Del. Dr. Esteve, S.A. Imidazo[2,1-b]thiazole derivatives, their preparation and use as medicaments
CN105209453B (zh) 2012-10-16 2017-06-20 詹森药业有限公司 ROR‑γ‑T的亚甲基连接的喹啉基调节剂
CN104884448A (zh) 2012-10-16 2015-09-02 詹森药业有限公司 Rorγt的杂芳基连接的喹啉基调节剂
SG11201502935VA (en) 2012-10-16 2015-09-29 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of ror-gamma-t
JP2016503395A (ja) 2012-10-31 2016-02-04 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 病害生物防除剤としての複素環化合物
CN103833771A (zh) * 2012-11-22 2014-06-04 天津滨江药物研发有限公司 作为蛋白激酶Mek抑制剂的苯并五元杂环化合物及其制备方法和用途
CN103073491A (zh) * 2013-01-25 2013-05-01 桑迪亚医药技术（上海）有限责任公司 一种2-（5,7-二氟-6-喹啉基）乙酸/丙酸（酯）的合成方法
US9328095B2 (en) 2013-10-15 2016-05-03 Janssen Pharmaceutica Nv Heteroaryl linked quinolinyl modulators of RORgammat
US9284308B2 (en) 2013-10-15 2016-03-15 Janssen Pharmaceutica Nv Methylene linked quinolinyl modulators of RORγt
US9221804B2 (en) 2013-10-15 2015-12-29 Janssen Pharmaceutica Nv Secondary alcohol quinolinyl modulators of RORγt
US10555941B2 (en) 2013-10-15 2020-02-11 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of RORγt
US9403816B2 (en) 2013-10-15 2016-08-02 Janssen Pharmaceutica Nv Phenyl linked quinolinyl modulators of RORγt
US9624225B2 (en) 2013-10-15 2017-04-18 Janssen Pharmaceutica Nv Quinolinyl modulators of RORγt
CA2926339A1 (en) 2013-10-15 2015-04-23 Janssen Pharmaceutica Nv Alkyl linked quinolinyl modulators of roryt
US10398774B2 (en) 2014-12-09 2019-09-03 INSERM (Institut National de la Santé et de la Recherche Médicale) Human monoclonal antibodies against AXL
WO2016135041A1 (en) 2015-02-26 2016-09-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Fusion proteins and antibodies comprising thereof for promoting apoptosis
GR1009565B (el) * 2016-07-14 2019-08-06 Galenica Α.Ε. Νεα παραγωγα 1,2,4-τριαζολο-[3,4-b]-1,3,4-θειαδιαζολιων
ES2896331T3 (es) * 2017-07-10 2022-02-24 UCB Biopharma SRL Derivados del 2-oxo-1,3-oxazolidinilimidazotiadiazol
CN109897054B (zh) * 2017-12-08 2021-12-10 中国药科大学 三唑并噻二唑类c-Met激酶抑制剂的制备方法及其用途
MX2020011275A (es) 2018-04-25 2020-11-13 Bayer Ag Novedosos compuestos de heteroaril-triazol y hetroaril[-]tetrazol como plaguicidas.
EP3805234B1 (en) * 2018-05-24 2024-09-04 Guangzhou Henovcom Bioscience Co., Ltd. Aromatic heterocyclic compound, and pharmaceutical composition and use thereof
KR20220038402A (ko) 2019-07-23 2022-03-28 바이엘 악티엔게젤샤프트 살충제로서의 신규 헤테로아릴-트리아졸 화합물
UY38796A (es) 2019-07-23 2021-02-26 Bayer Ag Novedosos compuestos de heteroaril-triazol como plaguicidas

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050583A (en) * 1958-10-07 1962-08-21 Stephens Trusonic Inc Controllable stereophonic electroacoustic network
GB9416162D0 (en) * 1994-08-10 1994-09-28 Merck Sharp & Dohme Therapeutic agents
GB9918035D0 (en) * 1999-07-30 1999-09-29 Novartis Ag Organic compounds
TW200301251A (en) * 2001-12-20 2003-07-01 Wyeth Corp Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
UA78999C2 (en) * 2002-06-04 2007-05-10 Wyeth Corp 1-(aminoalkyl)-3-sulfonylazaindoles as ligands of 5-hydroxytryptamine-6
TW200403243A (en) * 2002-07-18 2004-03-01 Wyeth Corp 1-Heterocyclylalkyl-3-sulfonylazaindole or-azaindazole derivatives as 5-hydroxytryptamine-6 ligands
EP1554272B1 (en) * 2002-08-09 2006-10-25 Eli Lilly And Company Benzimidazoles and benzothiazoles as inhibitors of map kinase
AU2003298942A1 (en) * 2002-12-11 2004-06-30 Merck And Co., Inc. Tyrosine kinase inhibitors
PA8595001A1 (es) * 2003-03-04 2004-09-28 Pfizer Prod Inc Nuevos compuestos heteroaromaticos condensados que son inhibidores del factor de crecimiento transforante (tgf)
GB0405055D0 (en) * 2004-03-05 2004-04-07 Eisai London Res Lab Ltd JNK inhibitors
DE602005027825D1 (de) * 2004-03-30 2011-06-16 Vertex Pharma Als inhibitoren von jak und anderen proteinkinasen geeignete azaindole
US7439246B2 (en) * 2004-06-28 2008-10-21 Bristol-Myers Squibb Company Fused heterocyclic kinase inhibitors
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7361764B2 (en) * 2004-07-27 2008-04-22 Sgx Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
EP1781654A1 (en) * 2004-07-27 2007-05-09 SGX Pharmaceuticals, Inc. Pyrrolo-pyridine kinase modulators
AU2005269387A1 (en) * 2004-07-27 2006-02-09 Sgx Pharmaceuticals, Inc. Fused ring heterocycle kinase modulators
CA2584368A1 (en) * 2004-10-19 2006-04-27 Arqule, Inc. Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
FR2890072A1 (fr) * 2005-09-01 2007-03-02 Fournier S A Sa Lab Nouveaux composesde pyrrolopyridine
EP2298770A1 (en) * 2005-11-03 2011-03-23 ChemBridge Corporation Heterocyclic compounds as TrkA modulators
EP1963329B1 (en) * 2005-11-30 2013-01-23 Vertex Pharmaceuticals Incorporated Inhibitors of c-met and uses thereof

Also Published As

Publication number Publication date
CN101678014A (zh) 2010-03-24
US20090156594A1 (en) 2009-06-18
KR20090130212A (ko) 2009-12-18
BRPI0812360A2 (pt) 2015-01-27
EP2162132A4 (en) 2013-01-16
AU2008254588A1 (en) 2008-11-27
KR101156845B1 (ko) 2012-06-18
JP2010528991A (ja) 2010-08-26
WO2008144767A1 (en) 2008-11-27
AU2008254588B2 (en) 2013-01-17
EP2162132A1 (en) 2010-03-17
MX2009012623A (es) 2009-12-11
CA2688823A1 (en) 2008-11-27
CN101678014B (zh) 2012-12-12

Similar Documents

Publication Publication Date Title
EA200971077A1 (ru) Гетероциклические модуляторы киназы
EA200970403A1 (ru) Бициклические триазолы в качестве модуляторов протеинкиназы
EA200970402A1 (ru) Триазолопиридазиновые модуляторы протеинкиназ
EA200901157A1 (ru) Конденсированные кольцевые гетероциклические модуляторы киназы
NO20070908L (no) Sammensmeltede ringheterocykelkinasemodulatorer
EA200970738A1 (ru) Ингибиторы активности akt
EA201170349A1 (ru) Модуляторы mif
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
TW200745109A (en) Pyrrolo-pyridine kinase modulators
EA200901313A1 (ru) Ингибиторы тирозинкиназы брутона
EA201790267A1 (ru) Новые модуляторы киназ
EA201001329A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201071089A1 (ru) Производные хиназолина как модуляторы raf-киназы и способы их применения
EA201001331A1 (ru) ГЕТЕРОЦИКЛИЧЕСКИЕ СОЕДИНЕНИЯ И СОДЕРЖАЩИЕ ИХ КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗ c-kit И PDGFR
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
TNSN07027A1 (en) Pyrrolo-pyridine kinase modulators
EA200900959A1 (ru) Ингибиторы мек
WO2008124849A3 (en) Pyrrolo-pyridine kinase modulators
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
NO20082476L (no) Bicykliske forbindelser med kinaseinhiberende aktivitet
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201290255A1 (ru) Способы и композиции для лечения рака
EA200901486A1 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ, КАК ИНГИБИТОРЫ КИНАЗЫ c-KIT И PDGFR
EA201290103A1 (ru) Гетероциклические соединения и их использование
PH12015501955B1 (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases